TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
Study TMC114-C214 is a randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114 boosted with low dose ritonavir (RTV) versus Kaletra (LPV)/RTV in lopinavir-naïve treatment-experienced HIV-1 infected patients.
Epistemonikos ID: e7e62fbf828ec6b6193378e328f526400b7cd0d6
First added on: Dec 01, 2021